Steritas LLC., a company dedicated to enhancing care for steroid-treated patients, today announced a licensing agreement with argenx, a global immunology company, for use of its STOX® Suite of steroid ...
Sage Therapeutics has been working in the area of steroid-derived compounds that affect CNS receptor signaling.